"The Role of Topical Anesthesia in Flexible Nasofibrolaryngoscopy" Is It Necessary?
Simple and Sensitive Method for the Simultaneous Estimation of Drotaverine HCL and Aceclofenac Using RP-HPLC
Obesity-Related Hormones and Metabolic Risk Factors: A Randomized Trial of Diet plus Either Strength or Aerobic Training versus Diet Alone in Overweight Participants
Obesity-Related Hormones and Metabolic Risk Factors | Ommega Online Publishers
There is debate about the additive effects of exercise in conjunction
with diet to treat obesity, and not much is known about the differential
effects of strength versus aerobic training. This randomized controlled
trial examined the effects of diet plus strength training, diet plus
aerobic training, or diet only on metabolic risk factors associated with
obesity. Eighty-one overweight and obese participants completed the
8-week intervention. All participants received an energy-restrictive
formula diet with an energy content based on 70% of measured resting
metabolic rate (RMR). Participants assigned to an exercise group trained
3 days/week under supervision. Anthropometrics and fasting hormones
were assessed pre- and post-intervention. Mean weight loss (8.5± 4.3kg
SD) did not differ between groups nor did reductions in BMI or body fat,
although the diet plus strength training group showed marginally
greater lean mass retention. There were significant improvements in the
values and number of metabolic syndrome risk factors, and decreases in
insulin concentrations and insulin resistance, which did not vary
between groups. For men, testosterone increased significantly more in
the diet plus aerobic training as compared to the other groups. As
compared to diet alone, the addition of strength or aerobic training did
not improve changes in BMI, body fat or metabolic risk factors although
the diet plus strength training group showed a trend toward
preservation of lean mass, and the diet plus aerobic group in men
resulted in increased testosterone concentrations.
http://www.ommegaonline.com/form/issues/Obesity-Related-Hormones-and-Metabolic-Risk-Factors.php
High Blood Pressures
High Blood Pressures | Ommega Online Publishers
Case Stem (one to two paragraphs on pertinent
patient and scenario information-this should be the stem for the
learner and should include location, physician/help availability, family
present, etc.)
60 year old male with no past medical or surgical history presented to
the Emergency Room with sudden onset dyspnea and palpitations[1,2].
For the past 2 weeks, he had been experiencing include intermittent
headaches, palpitations, anxiety, and occasional shortness of breath on
exertion, which is what brought him to the hospital. This morning, his
wife noted increased anxiety leading to “he can’t catch his breath.”
Work up includes an Electrocardiogram, cardiac enzymes, chest x-ray,
stress test, and transthoracic echocardiography, all of which were
normal. Incidentally, a abdominal Computerized tomography (CT) scan was
performed, and an acute appendicitis could not be ruled out, so he was
sent to the Operating Room to do a diagnostic laparoscopy and
appendectomy.
Background and briefing information for Facilitator/coordinator's eyes only
In the ER, his blood pressure ranged from noninvasive systolic 140-280
millimeters mercury over diastolic 30-150 millimeters mercury, so a CT
(computerized tomography) abdomen showed a 6-centimeter round mass
retroperitoneally on the right adrenal gland suggesting
pheochromocytoma[4,5], but this was missed initially as it only showed a
possible acute appendicitis. Serum epinephrine was 18.6
nanogram/milliliter (normal: 0.01-0.18 nanogram/milliliter),
norepinephrine 24.2 nanogram/milliliter (normal: 0.06-0.45
nanogram/milliliter), and dopamine 4.8 nanogram/milliliter (normal
0-0.09 nanogram/milliliter). No metaiodobenzylguanidine (MIGB) scan
performed because of acute renal failure.
http://www.ommegaonline.com/form/issues/High-Blood-Pressures.php
Fructose Intake and Circulating Triglycerides: An Examination of the Role of APOC 3
Fructose Intake and Circulating Triglycerides: An Examination of the Role of APOC 3 | Ommega Online Publishers
Fructose consumption can lead to marked increases in plasma
triglycerides in both humans and laboratory animals. We have observed
that overnight access to a 16% fructose solution can promote
hypertriglyceridemia in rats. Several investigators have suggested that
APOC 3 may be implicated in promoting fructose-induced
hypertriglyceridemia. We have examined the role of APOC 3 in liver and
blood taken from rats that had been given access to a fructose solution
overnight as a supplement to standard laboratory chow. Hepatic APOC3
mRNA expression from fructose alone resulted in a 14 % reduction
compared to control. Interestingly, hepatic APOC3 expression was
increased by about 250% in sucrose, high fructose corn syrup and glucose
groups. The serum protein levels of APOC3 did not differ across groups.
Contrary to our hypothesis, these results indicate that glucose
containing sugars increased hepatic APOC3 mRNA expression but no sugar
was capable of increasing the serum protein level.
http://www.ommegaonline.com/form/issues/Fructose-Intake-and-Circulating-Triglycerides.php
Formulation and Evaluation of Self-Nanoemulsifying Powder of Ezetimibe
Formulation and Evaluation of Self-Nanoemulsifying Powder of Ezetimibe | ommega online publishers
Ezetimibe (EZT) is the selective cholesterol absorption inhibitor. It is
indicated for the treatment of primary hypercholesterolemia. The
current investigation was aimed to formulation and evaluation of self
nanoemulsifying
powder (SNEP) for EZT to enhance solubility and dissolution rate and
this will leads to minimize the variability in absorption. Solubility of
drug was determined in different vehicles. Pseudo ternary phase diagram
generated using
Acrysol EL 135, Tween 80 and Trancutol P. The SNEP was prepared by
adsorbing the optimized liquid SNEDDS on to Fujicalin as carrier. The
SNEP characterized by micromeritic properties, differential scanning
studies,
percentage transmittance, emulsification time and zeta potential. The
optimized formulation had shown the smallest particle size, less
emulsification time, good % transmittance and good in vitro release. The in vitro dissolution
rate and Ex vivo permeation rate of the drug from the SNEP was
significantly higher than that of the plain drug and its suspension
respectively.
http://www.ommegaonline.com/form/issues/Formulation-and-Evaluation-of-Self-Nanoemulsifying-Powder-of-Ezetimibe.php
Fasting C-Peptide Index May be the Strongest Predictor for Detecting Effectiveness of Glycemic Control by GLP-1 Analogue, Liraglutide Therapy for Japanese Type 2 Diabetic Patients
Strongest Predictor for Detecting Effectiveness of Glycemic Control by GLP-1 Analogue | Ommega Online Publishers
Liraglutide (Victoza, Novo Nordisk Pharma Ltd.), a GLP-1 analogue
preparation for diabetes mellitus has been reported to potently reduce
the blood sugar level and decrease the body weight when injected once a
day. As the risk of hypoglycemia is low, it has been used as an
epoch-making drug in a rapidly increasing number of patients. In this
study, we investigated the effects of liraglutide subcutaneously
injected once a day in 48 patients with type 2 diabetes who had been
treated at the outpatient clinic of the Diabetes Center in Yokohama
Rosai hospital without admission. After 3 - month administration, the
mean HbA1c value was significantly decreased (from 8.61 to 8.04%), and
the mean body weight was also significantly reduced (from 71.0 to 69.2
kg). However, there were marked individual differences in the effects.
We compared background factors between groups with and without
improvement. The results showed that liraglutide was particularly
effective in patients with a short duration of diabetes in whom
endogenous insulin secretion, which was evaluated by examining fasting
C-peptide with fasting sugar level, was well maintained. Furthermore, we
examined the characteristics of eating behavior before and after
administration using a questionnaire. In patients with a significant
decrease in the blood sugar level, there was a marked improvement in the
eating behavior pattern. Therefore, not only a decrease in the blood
sugar level related to improved ability of endogenous insulin secretion
but also the improvement of a patient’s eating behavior was closely
associated with a decrease in the blood sugar level after liraglutide
administration.
http://www.ommegaonline.com/form/issues/Fasting-C-Peptide-Index-May-be-the-Strongest-Predictor.php
Factors Associated with Metabolic Syndrome in Patients with Mental Disorders in Mexico
Factors Associated with Metabolic Syndrome in Patients with Mental Disorders in Mexico | ommega Online Publishers
Metabolic Syndrome (MS) is defined by the presence of biochemical,
physiological, and anthropometric abnormalities linked to insulin
resistance, which increase the risk of diabetes mellitus and/or
cardiovascular disease, as well as alterations such as abdominal
obesity, glucose intolerance or diabetes mellitus, hypertension and
dyslipidemia [1] .
According to the International Diabetes Federation (IDF), abdominal
obesity is not currently a prerequisite for MS, but it is important
criterions within those five that classify the syndrome.[1,2]
They recommend that the threshold for waist circumference that would
define abdominal obesity should be established according to the country
and population type, considering factors such as ethnicity.
http://www.ommegaonline.com/form/issues/Factors-Associated-with-Metabolic-Syndrome-in-Patients-with-Mental-Disorders-in-Mexico.php
Discovery of Adiponectin and its Future Prospect
Contralateral Prophylactic Mastectomy: Characteristics Influencing Utilization
Asymmetry of Symptoms and Signs in Multiple System Atrophy
It has been widely recognized that some of the symptoms and signs of
multiple system atrophy (MSA) emerge with laterality, but only a few
studies have evaluated this issue comprehensively. Small-scale case
reports that have been published thus far suggest that laterality in MSA
is a
rather rare finding.
In order to examine the prevalence and characteristics of laterality in
symptoms and signs in MSA, we retrospectively investigated the records
of 155 MSA patients. Among all the patients, 39% had episodes that
suggested the presence of laterality in their illness history.
The MSA with predominant parkinsonism (MSA-P) patients presented with
more episodes of laterality than the MSA with cerebellar features
(MSA-C) patients. Among the episodes, laterality was more frequent in
parkinsonism than for the cerebellar symptoms.Interestingly, these
symptoms were more prevalent at the left side of the body. Laterality in
the cerebellar signs was present in 63% of the MSA-C patients and
laterality
in parkinsonism was exhibited by 64% of the MSA-P patients.
Interestingly, cerebellar signs, parkinsonism, and Horner's sign were
all observed
predominantly at the left side.
Thus, we concluded that a significant number of MSA patients present
with laterality in both symptoms and signs and that more interestingly,
these are predominantly observed at the left side.
http://www.ommegaonline.com/form/issues/Asymmetry-of-Symptoms-Signs-in-Multiple-System-Atrophy.php